Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Amortizatization of Intangibles: 2021-2024

Historic Amortizatization of Intangibles for Janux Therapeutics (JANX) over the last 4 years, with Dec 2024 value amounting to $10.6 million.

  • Janux Therapeutics' Amortizatization of Intangibles rose 59.52% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year increase of 74.68%. This contributed to the annual value of $10.6 million for FY2024, which is 37.68% up from last year.
  • Janux Therapeutics' Amortizatization of Intangibles amounted to $10.6 million in FY2024, which was up 37.68% from $7.7 million recorded in FY2023.
  • Over the past 5 years, Janux Therapeutics' Amortizatization of Intangibles peaked at $10.6 million during FY2024, and registered a low of $172,000 during FY2021.
  • For the 3-year period, Janux Therapeutics' Amortizatization of Intangibles averaged around $6.8 million, with its median value being $7.7 million (2023).
  • Data for Janux Therapeutics' Amortizatization of Intangibles shows a peak YoY soared of 1,169.19% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Janux Therapeutics' Amortizatization of Intangibles stood at $172,000 in 2021, then surged by 1,169.19% to $2.2 million in 2022, then surged by 252.18% to $7.7 million in 2023, then soared by 37.68% to $10.6 million in 2024.